Education about folic acid: The ob-gyn's role in preventing neural tube defects

Emergency Medicine

Volumn 44, Issue 3, 1999, Pages 39-53

  Perlow, Jordan H ^a,b,c  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b Phoenix Perinatal Associates   (United States)

^c Department of the March of Dimes ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004984696     PISSN: 00136654     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Centers for Disease Control and Prevention. Use of folic acid for the prevention of spina bifida and other neural tube defects 1983-1991. MMWR. 1991;40:513-515.
2. Centers for Disease Control and Prevention. Knowledge about folic acid and use of multivitamins containing folic acid among reproductive aged women-Georgia 1995. MMWR. 1996;45:793-795.
3. Harmon JP, Hiett AF, Palmer CG, et al. Prenatal ultrasound detection of isolated neural tube defects: is cytogenetic evaluation warranted? Am J Obstet Gynecol. 1995;86:595-599.
4. Centers for Disease Control and Prevention. Economic burden of spina bifida-United States, 1980-1990. MMWR. 1989;38:264-267.
5. Waller DK, Mills JL, Simpson JL, et al. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol. 1994;170:541-544.
6. Shaw GM, Velie EM, Schaffer D: Risk of neural tube defect affected pregnancies among obese women. JAMA. 1996;275:1093-1096.
7. Gonzalez MJ, Schmitz KJ, Matos MI, et al. Folate supplementation and neural tube defects: a review of a public health issue. P R Health Sci J. 1997;16:387-393.
8. Stein Z, Susser M. Maternal starvation and birth defects. In Kelly S, ed. Birth Defects: Risks and Consequences. New York, NY: Academic Press, Inc; 1976.
9. Leck I. Correlations of malformation frequency with environmental and genetic attributes in man. In Wilson JG, Fraser FC, eds. Handbook of Teratology. New York, NY: Plenum Press; 1977: 241-324.
10. 12 metabolism in families with spina bifida offspring. QJM. 1997;90:505-510.
11. Wild J, Seller MJ, Schorah CJ, et al. Investigations of folate intake and metabolism in women who have had two pregnancies complicated by neural tube defects. Br J Obstet Gynaecol. 1994;101:197-202.
12. Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995;345:149-151.
13. 12 are independent risk factors for neural tube defects. QJM. 1993;86:703-708.
14. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child. 1976;51:944-949.
15. Yates JR, Ferguson-Smith MA, Shenkin A, et al. Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin Genet. 1987;31:279-287.
16. 12 in relation to neural tube defects. Br J Obstet Gynaecol. 1996;103:319-324.
17. Smithells RW, Hibbard ED. Folic acid metabolism and human embryopathy. Lancet. 1965;1:1254-1256.
18. Mulinare J, Cordero JF, Erickson JD, et al. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988;260:3141-3145.
19. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: evidence from case-control study in Western Australia. Med J Aust. 1989;150:613-619.
20. Mills JL, Rhoads GG, Simpson JL, et al. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. N Engl J Med. 1989;321:430-435.
21. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989;262:1634.
22. Laurence KM, James N, Miller M, et al. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ. 1981;282:1509-1511.
23. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-137.
24. Smithells RW, Nevin NC, Seller MJ, et al. Further experience of vitamin supplementation for the prevention of neural tube defect recurrences. Lancet. 1983;1:1027-1031.
25. Vergel RG, Sanchez LR, Heredero BL, et al. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn. 1990;10:149-152.
26. Friel JK, Frecker M, Fraser FC. Nutritional patterns of mothers of children with neural tube defects in Newfoundland. Am J Med Genet. 1995;55:195-199.
27. Czeil AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-1835.
28. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR. 1992;41(No.RR-14):1-7.
29. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995;346:1070-1071.
30. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentrations. Circulation. 1996;93:7-9.
31. Bjorke-Monsen AL, Ueland PM, Schneede J, et al. Elevated plasma homocysteine and C677T mutation of the methylenetetrahydrofoate reductase gene in patients with spina bifida. QJM. 1997;90:593-596.
32. Finnell RH, Greer KA, Barber RC, et al. Neural tube and craniofacial defects with special emphasis on folate pathway genes. Crit Rev Oral Biol Med. 1998;9:38-53.
33. Eskes TK. Neural tube defects, vitamins and homocysteine. Eur J Pediatr. 1998:157(Suppl2):S139-S141.
34. Lucock MD, Wild J, Lumb CH, et al. Risk of neural tube defect-affected pregnancy is associated with a block in maternal one-carbon metabolism at the level of N-5-methyltetrahydrofolate: homocysteine methyltransferase. Biochem Mol Med. 1997;61:28-40.
35. Malinow MR, Duell PB, Hess DL, et al. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med. 1998;338:1009-1015.
36. Centers for Disease Control and Prevention. Knowledge and use of folic acid by women of childbearing age-United States, 1997. MMWR. 1997; 46:721-723.
37. Perlow JH. Knowledge and preconceptional use of folic acid in patients presenting for high risk pregnancy care. Am J Obstet Gynecol. 1999;180:S68. Abstract.
38. Cuskelly GJ, McNulty H, Scott JM. Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet. 1996;347:657-659.
39. 12. Am J Clin Nutr. 1997;65:1889-1890.
40. Oakley GP Jr. Eat right and take a multivitamin. N Engl J Med. 1998;338:1060-1061.
41. Daly S, Mills JL, Molloy AM, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet. 1997;350:1666-1669.
42. Wald NJ, Law M, Jordan R. Folic acid food fortification to prevent neural tube defects. Lancet. 1998;351:834-835.
43. Swain RA, St. Clair L. The role of folic acid in deficiency states and prevention of disease. J Fam Pract. 1997;44:138-144.
44. Oakley Jr. GP. Doubling the number of women consuming vitamin supplement pills containing folic acid: an urgently needed birth defect prevention complement to the folic acid fortification of cereal grains. Reprod Toxicol. 1997;11:579-581.
45. Hospital for Sick Children, Toronto, Ontario, Canada Website http://www.motherisk.orgy/recomm/folic.htm.